[{"Assets_0_FY_USD":431613000.0,"CommonStockSharesOutstanding_0_FY_shares":82903567.0,"EarningsPerShareBasic_1_FY_USD":0.6,"EarningsPerShareBasic_4_FY_USD":0.13,"EarningsPerShareDiluted_1_FY_USD":0.58,"EarningsPerShareDiluted_4_FY_USD":0.13,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-99180000.0,"NetIncomeLoss_1_FY_USD":48444000.0,"NetIncomeLoss_4_FY_USD":9132000.0,"StockholdersEquity_0_FY_USD":199568000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":82996000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":70381000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":80486000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":69742000.0,"Ticker":"SRNE","CIK":"850261","name":"SORRENTO THERAPEUTICS, INC.","OfficialName":"Sorrento Therapeutics Inc.  Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"636044097.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20180316"}]